Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian T Ruff

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trialRiccardo Proietti, Michael Gerard Palazzolo, Christian T Ruff, et al.
Journal of Virology|August 7, 2002
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infectionTheodore C Pierson, Yan Zhou, Tara L Kieffer, et al.
Nature Medicine|December 7, 2021
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trialChristian T Ruff, Michelle Baron, KyungAh Im, et al.
Journal of Virology|March 22, 2002
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replicationTheodore C Pierson, Tara L Kieffer, Christian T Ruff, et al.
The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.
Journal of Diabetes and Its Complications|June 13, 2024
Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysisAnika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Circulation|July 1, 2016
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialErin A Bohula, Robert P Giugliano, Christian T Ruff, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2013
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trialBram J Geller, Jessica L Mega, David A Morrow, et al.
Circulation|December 27, 2011
American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)Marc P Bonaca, Stephen D Wiviott, Eugene Braunwald, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 14, 2015
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin--Insights From the ENGAGE AF-TIMI 48 TrialYuichi J Shimada, Takeshi Yamashita, Yukihiro Koretsune, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trialRiccardo Proietti, Michael Gerard Palazzolo, Christian T Ruff, et al.
Journal of Virology|August 7, 2002
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infectionTheodore C Pierson, Yan Zhou, Tara L Kieffer, et al.
Nature Medicine|December 7, 2021
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trialChristian T Ruff, Michelle Baron, KyungAh Im, et al.
Journal of Virology|March 22, 2002
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replicationTheodore C Pierson, Tara L Kieffer, Christian T Ruff, et al.
The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.
Journal of Diabetes and Its Complications|June 13, 2024
Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysisAnika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Circulation|July 1, 2016
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialErin A Bohula, Robert P Giugliano, Christian T Ruff, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2013
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trialBram J Geller, Jessica L Mega, David A Morrow, et al.
Circulation|December 27, 2011
American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)Marc P Bonaca, Stephen D Wiviott, Eugene Braunwald, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 14, 2015
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin--Insights From the ENGAGE AF-TIMI 48 TrialYuichi J Shimada, Takeshi Yamashita, Yukihiro Koretsune, et al.
Pageof 20